SOURCE: IDenta Corp.

June 10, 2008 10:15 ET

IDenta to Present Heroin Precursor Kit to United Nations Conference in Paris on Thursday -- IDenta Drug Precursor Products to Engage Crucial Front on the International War on Drugs

JERUSALEM--(Marketwire - June 10, 2008) - IDenta Corp. (PINKSHEETS: IDTA) announced today that the company will make a special presentation to The International Narcotics Control Board (INCB) of the United Nations on Thursday, June 12, 2008. At the conference, being hosted by French high position officials and to be held in Paris, France, local Identa representatives (IBTEC) will introduce the first of IDenta's new line of drug precursor products. The Heroin Precursor detector, developed at the request of the French National Chemical Precursors Control Unit, Ministry of Economy, Finance and Industry, is expected to be a major breakthrough in the international war on illicit drugs and heroin production. The Paris conference will be focusing on the problem of heroin manufactured in Afghanistan (Afghanistan is the main supplier of the heroin drug in the world).

"We are honored to be given the opportunity to make this presentation before this special conference," said IDTA CEO Yaacov Shoham. "We believe that the development of IDenta's new line of drug precursors is a technological advancement that will give law enforcement agencies around the world a major new tool in identifying chemical shipments that are intended to be part of clandestine chemistry. IDenta On-site Precursor Detectors will enable law enforcement agencies to expand their search for illicit substances necessary for the development of illegal drugs like heroin, and stop these illegal shipments before they make it to manufacturing plants in major heroin producing countries like Afghanistan."

Research and development of this first new IDenta precursor product was led by Mr. Baruch Glattstein, IDenta's Chief Scientist, who holds numerous patents in the fields of drug and explosive detection. The new product being demonstrated at the Paris Conference will detect acetic anhydride (AA), a clear, colorless liquid. Morphine, one of many alkaloids in opium, is first extracted out of opium by precipitation and then turned into heroin by heating it with acetic anhydride. AA is the most commonly used chemical agent in heroin processing and is virtually irreplaceable according to the U.S. Drug Enforcement Agency.

IDenta is in the process now of applying for patents for its new precursor products. IDTA expects to soon be marketing the new line of precursor products around the world and believes that they have the potential to be a significant new source of revenue for the company.

About The International Narcotics Control Board (INCB)

The International Narcotics Control Board (INCB) is the independent and quasi-judicial monitoring body for the implementation of the United Nations international drug control conventions. Broadly speaking, INCB deals with the licit manufacture of, trade in and use of drugs, INCB endeavors in cooperation with world governments, working to ensure that adequate supplies of drugs are available for medical and scientific uses but that the diversion of drugs from licit sources to illicit channels does not occur. The INCB monitors Governments' control over chemicals used in the illicit manufacture of drugs and assists them in preventing the diversion of those chemicals into the illicit traffic. See: http://www.incb.org/incb/en/mandate.html

ABOUT IDENTA

Since 2003, IDenta Corporation has become recognized as a world-wide leader in the development of proprietary on-site drug, drug precursor and explosive detection kits. IDenta develops, manufactures and distributes products for the both professional and civil markets which consistently pass the highest qualifications and testing procedures of law enforcement and security agencies around the world. Information concerning IDenta's entire product line may be found at www.IDenta.biz.

DISCLAIMER

Certain of the statements contained herein may be, within the meaning of the federal securities laws, "forward-looking statements" that are subject to risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These forward-looking statements are based on management's expectations as of the date hereof, and the company does not undertake any responsibility to update any of these statements in the future.

Contact Information

  • For Investor Relations, lobbying interests or information concerning
    IDenta's products internationally or the development of new chemical
    detectors contact:
    Yaacov Shoham
    IDenta Corp.
    CEO
    Tel: +972-52-6554487
    fpi@drugsdetector.com

    For Investor Relations in the US, contact:
    Randy Jacobs
    Corporate Spokesman
    IDentaNews@sitcomllc.com
    1-800-316-9437

    For information about the Accutest® - IDenta products in the US, please
    contact:
    Mr. Eyal Golan
    COO
    JANT PHARMACAL CORPORATION
    16255 Ventura Blvd. #505
    Encino, CA 91436
    Toll Free: 800-676-5565
    http://www.accutest.net